The efficiency and precision of cancer treatments, which may be surgical removal, radiotherapy, chemotherapy, or a combination of second and third depends upon the stage and type of cancer. Targeting CD47 and Signal inhibitory receptor alpha protein interactions (SIRPα) has evolved as one of several such methods of cancer therapy. Continue reading Anti-CD47 antibody: A new hope for cancer treatment
Kelli Gallacher, University of Bristol
It may only be early in 2018, but we have already been treated to some exciting science news. Last week, a study published in Science described a blood test that is able to detect proteins and genes that are characteristic of eight common forms of cancer; ovarian, lung, breast, liver, stomach, pancreatic, colon and oesophageal. This could have a huge impact in how we diagnose cancer – but how far have we come and how soon can we see the test in practice?
Continue reading CancerSEEK – the ‘holy grail’ of cancer diagnosis?